-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 R2RSD40nE/p33RnJkkYpq4kh+s0pFP8CPzkPbHFsyxjFis/LvoaaaoBetgr1kB71
 Mwzy80l7hZd7YDTRauBZdQ==

<SEC-DOCUMENT>0001282695-07-000002.txt : 20070118
<SEC-HEADER>0001282695-07-000002.hdr.sgml : 20070118
<ACCEPTANCE-DATETIME>20070103150552
ACCESSION NUMBER:		0001282695-07-000002
CONFORMED SUBMISSION TYPE:	NT 10-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20060930
FILED AS OF DATE:		20070103
DATE AS OF CHANGE:		20070103
EFFECTIVENESS DATE:		20070103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		NT 10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	002-90539
		FILM NUMBER:		07503820

	BUSINESS ADDRESS:	
		STREET 1:		25 HEALTH SCIENCES DRIVE
		STREET 2:		SUITE 113
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631 444 6861

	MAIL ADDRESS:	
		STREET 1:		25 HEALTH SCIENCES DRIVE
		STREET 2:		SUITE 113
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-K
<SEQUENCE>1
<FILENAME>e65885_12b-25.txt
<DESCRIPTION>NOTIFICATION OF LATE FILING
<TEXT>
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                        Commission File Number: 002-78682

                           NOTIFICATION OF LATE FILING

|X| Form 10-K     |_| Form 20-F     |_| Form 11-K
|_| Form 10-Q     |_| Form 10-D     |_| Form N-SAR

For Period Ended: September 30, 2006

|_| Transition Report on Form 10-K
|_| Transition Report on Form 20-F
|_| Transition Report on Form 11-k
|_| Transition Report on Form 10-Q
|_| Transition Report on Form N-SAR

For the Transition Period Ended:__________________

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:

- --------------------------------------------------------------------------------


PART I - REGISTRANT INFORMATION

Applied DNA Sciences, Inc.
- --------------------------------------------------------------------------------
Full name of registrant

- --------------------------------------------------------------------------------
Former name if applicable

25 Health Sciences Drive, Suite 113
- --------------------------------------------------------------------------------
Address of principal executive office

Stony Brook, New York 11790
- --------------------------------------------------------------------------------
City, state and zip code



<PAGE>


PART II - RULE 12b-25 (b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

    | (a) The reasons  described in  reasonable  detail in Part III of this form
    | could not be eliminated without unreasonable effort or expense;
    |
    | (b) The subject annual report,  semi-annual  report,  transition report on
    | Form 10-K,  Form 20-F,  Form 11-K,  Form N-SAR or Form  N-CSR,  or portion
    | thereof,  will be filed on or before the fifteenth  calendar day following
[X] | the  prescribed  due date; or the subject  quarterly  report or transition
    | report on Form  10-Q or  subject  distribution  report  on Form  10-D,  or
    | portion  thereof,  will be filed  on or  before  the  fifth  calendar  day
    | following the prescribed due date; and
    |
    | (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
    | has been attached if applicable.


PART III - NARRATIVE

State below in reasonable  detail the reasons why Forms 10-K,  20-F, 11-K, 10-Q,
10-D, N-SAR,  N-CSR, or the transition report, or portion thereof,  could not be
filed within the prescribed time period.

      Applied DNA Sciences,  Inc. (the "Company") is filing this Notification of
Late Filing on Form 12b-25 with respect to the  Company's  Annual Report on Form
10-KSB for the year ended September 30, 2006 (the "Form 10-KSB"). The Company is
unable,  without  unreasonable  effort and expense, to file the Form 10-KSB on a
timely  basis  due  to  unforeseen  delays  in  the  collection  and  review  of
information  and the  completion  of drafting the  necessary  responses to items
required to be included in the Form 10-KSB.


      The Company is currently  working with its independent  registered  public
accounting  firm to finalize the audit of its financial  statements for the year
ended  September 30, 2006.  The Company  expects that these  activities  will be
completed and the Form 10-KSB will be filed no later than January 16, 2007.




<PAGE>


PART IV -OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
notification

  James A. Hayward                     (631)                    444-6862
  ----------------                   -----------            ------------------
       (Name)                        (Area Code)            (Telephone Number)

(2) Have all other  periodic  reports  required under Section 13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  or for such  shorter  period  that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).

                            |X| Yes           |_| No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof?

                            |_| Yes           |X| No

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.


                           Applied DNA Sciences, Inc.

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.

Dated: January 3, 2007                      By:  /s/ JAMES A. HAYWARD
                                                 ----------------------------
                                                     James A. Hayward
                                                     Chief Executive Officer

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
